Bank of Nova Scotia
IOVA icon

Bank of Nova Scotia’s Iovance Biotherapeutics IOVA Stock Holding History

Bank of Nova Scotia’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,315
Closed -$72.3K – 1183
2022
Q4 		$72.3K Sell
11,315
-6,085
-35% -$47.5K ﹤0.01% 1145
2022
Q3 		$167K Sell
17,400
-1,010,071
-98% -$11.6M ﹤0.01% 1105
2022
Q2 		$11.3M Buy
1,027,471
+29,471
+3% +$386K 0.03% 353
2022
Q1 		$16.6M Buy
+998,000
New +$15.4M 0.03% 356

Other funds holding IOVA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of Nova Scotia's IOVA Position: Q1 2023 in Review

Bank of Nova Scotia sold out of Iovance Biotherapeutics (IOVA) in Q1 2023, closing a stake of 11,315 shares — an estimated $72.3K sold.

Bank of Nova Scotia first reported a position in IOVA in Q1 2022 and held it in 4 quarters. The position peaked at $16.6M in Q1 2022. 228 funds tracked by Wall St. Rank hold IOVA as of Q1 2023.

  • Bank of Nova Scotia reported no remaining Iovance Biotherapeutics position as of Q1 2023 after selling out during the quarter.
  • Bank of Nova Scotia sold 11,315 Iovance Biotherapeutics shares in Q1 2023, an estimated $72.3K.
  • Bank of Nova Scotia first reported a position in Iovance Biotherapeutics in Q1 2022 and held it in 4 quarters.
  • Bank of Nova Scotia's Iovance Biotherapeutics position peaked at $16.6M in Q1 2022.
  • 228 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2023.

Based on Bank of Nova Scotia's 13F filing for Q1 2023, filed 11 May 2023.